Antibacterial activity of fluoroquinolones in combination with zidovudine

References

1. Hirsch M S. AIDS commentary. Azidothymidine. J Infect Dis 1988; 157:427–431
   [Google Scholar]
2. Mitsuya H, Broder S. Strategies for antiviral therapy in AIDS. Nature 1987; 325:773–778
   [Google Scholar]
3. Yarchoan R, Klecker RW, Weinhold KJ et al. Administra tion of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex. Lancet 1986; 1:575–580
   [Google Scholar]
4. Elwell L, Ferone R, Freeman GA et al. Antibacterial activity and mechanism of action of 3'-azido-3'-deoxythymidine (BW A509U). Antimicrob Agents Chemother 1987; 31:274–280
   [Google Scholar]
5. Lewin CS, Amyes SGB. Conditions required for the antibacterial activity of zidovudine. Eur J Clin Microbiol 1989; 8:737–741
   [Google Scholar]
6. Keith BR, White G, Wilson HR. In vivo efficacy of zidovudine (3'-azido-3'-deoxythymidine) in experimental gram-negative-bacterial infections. Antimicrob Agents Chemother 1989; 33:479–483
   [Google Scholar]
7. Smith JT, Lewin CS. Chemistry and mechanisms of action of the quinolone antibacterials. In: Andriole VT. (ed) The quinolones London: Academic Press; 19882382
   [Google Scholar]
8. Andriole VT. Clinical overview of newer 4-quinolone antibacterial agents. In: Andriole VT. (ed) The quinolones London: Academic Press; 1988155–200
   [Google Scholar]
9. Bogner T, Goebel FD. Recurrent salmonella bacteriaemia in a patient with acquired immunodeficiency syndrome. AIDS Forschung 1986; 1:669–671
   [Google Scholar]
10. Young LS. Treatable aspects of infection due to acquired immunodeficiency virus. Lancet 1987; 2:1503–1506
    [Google Scholar]
11. Rolston KV, Rodriguez S, Mansell PWA. Antimicrobial therapy for salmonella infections in acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988; 108:309
    [Google Scholar]
12. Jacobson MA, Hahn SM, Geberding JL, Lee B, Sande MA. Ciprofloxacin for salmonella bacteremia in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1989; 110:1027–1029
    [Google Scholar]
13. Sande MA. Antimicrobial therapy of infections in patients with AIDS—an overview. J Antimicrob Chemother 1989; 23:Suppl A63–65
    [Google Scholar]
14. Lewin CS, Smith JT. Interactions of the 4-quinolones with other antibacterials. J Med Microbiol 1989; 29:221–227
    [Google Scholar]
15. Smith JT. Awakening the slumbering potential of the 4-quinolone antibacterials. Pharm J 1984; 233:299–305
    [Google Scholar]
16. Lewin CS, Amyes SGB. The bactericidal activity of DR-3355, an optically active isomer of ofloxacin. J Med Microbiol 1989; 30:227–231
    [Google Scholar]
17. Lewin CS, Howard BMA, Ratcliffe NT, Smith JT. 4-quinolones and the SOS response. J Med Microbiol 1989; 29:139–144
    [Google Scholar]